John J Mallee

Title: John J Mallee: Innovator in Genetic Research

Introduction

John J Mallee is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of genetic research, particularly in the development of isolated DNA molecules. His work has implications for pharmacology and transgenic animal models.

Latest Patents

Mallee holds a patent for "Isolated DNA molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods." This patent discloses isolated nucleic acid molecules that encode a humanized version of a calcitonin gene-related peptide (CGRP) receptor. The invention includes modifications to the mammalian RAMP1 nucleotide sequence, specifically at amino acid 74, which allows the humanized CGRP receptors to achieve pharmacological profiles similar to the wild type human receptor. Additionally, the patent describes related recombinant vectors, hosts, and methods for generating these humanized receptors.

Career Highlights

John J Mallee is associated with Merck & Co., Inc., where he has been able to apply his expertise in genetic research. His work has contributed to advancements in understanding CGRP receptors and their pharmacological profiles.

Collaborations

Mallee has collaborated with notable colleagues such as Stefanie A Kane and Christopher A Salvatore. Their combined efforts have furthered research in the field of genetic engineering and pharmacology.

Conclusion

John J Mallee's innovative work in the field of genetic research has led to significant advancements in understanding CGRP receptors and their applications. His contributions continue to impact the scientific community and the development of new therapeutic methods.